Search Results 271-280 of 17725 for SC
The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose combination for subcutaneous ...
BMC Public Health. 2023. Washington R, Weis JA, Monger M, Burse N, Melvin SC, Omondi AA, Lohr AM, Njeru JW, Compretta CE, ...
... SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. EULAR/ACR classification criteria for ...
SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...
... SC, Beck GJ, Barnard J, Finet JE, Kwon D, Mathai SC, Mukherjee M, Tang WHW, Nair KS, Borlaug BA. Elevated Pulmonary Artery Wedge Pressure in Group 1 ...
... SC. A Learning Health System Approach to Hospital Quality Performance Benchmarking: The Composite Hospital Quality Index. Am J Med Qual. 2022 Jun 16 Epub ...
... SC, Chapman WC Jr, Cowan ML, Ciorba MA, Colonna M, Deepak P, SPARC IBD Investigators. Revealing hyperactivated IFN-gamma pathways in perianal fistulizing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.